| Financial Year |
March 31 2023 |
| Monetary Funds |
81,444,502.58 |
| Held-for-trading Financial Assets |
26,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
18,892,027.32 |
| Advances to Suppliers |
2,953,414.46 |
| Other Receivables |
13,494,870.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
35,576.85 |
| Dividend Receivable |
-- |
| Inventories |
461,032.67 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
22,398,958.97 |
| Total Current Assets |
165,644,806.51 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
4,304,174.06 |
| Investment Properties |
5,168,734.65 |
| Fixed Assetes |
2,311,383.57 |
| Under-construction Projects |
118,201,639.18 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
38,283,191.27 |
| R&D expenses |
-- |
| Goodwill |
15,765,217.97 |
| Long-Term Deferred and Prepaid Expenses |
5,347,673.78 |
| Deferred Income Tax Assets |
454,436.81 |
| Other Non-Current Assets |
800,000.00 |
| Sub-Total of Non-Current Assets |
191,710,180.65 |
| Total Assets |
357,354,987.16 |
| Short-Term Loans |
4,700,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
30,304,987.89 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,489,470.15 |
| Taxes Payable |
821,638.58 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
226,774,218.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
867,997.03 |
| Other Current Liabilities |
208,642.54 |
| Sub-Total of Current Liabilities |
269,644,329.98 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
5,450,675.16 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,673,367.33 |
| Total Liabilities |
275,317,697.31 |
| Paid-In Capital(Or Share Stock) |
884,460,000.00 |
| Capital Surplus |
487,743,382.88 |
| Surplus Reserve |
34,655,116.25 |
| LESS:Treasury Stock |
134,453,100.00 |
| Undistributed Profits |
-1,229,185,671.82 |
| Minority Stockholder's Interest |
38,817,562.54 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
43,219,727.31 |
| Owner's Equity（Stockholder's Equity） |
82,037,289.85 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
357,354,987.16 |
